MS
Meena Sanjiv Kapadi
About Meena Sanjiv Kapadi
Data last updated:
Meena Sanjiv Kapadi is a Director at Flamingo Pharmaceuticals Limited (since 2022), Director at B4u Broadband (India) Private Limited (since 2022) and Director at B4u Television Network India Limited (since 2022), and holds 1 more current directorship. The companies operate in Pharma, Media and Publishing and Real Estate and Construction. The 4 current companies with reported revenue have a combined latest revenue of ₹1,180 Cr; the largest is Flamingo Pharmaceuticals Limited at ₹637 Cr (FY 2026). Earlier, Meena Sanjiv Kapadi was a Director at Medibios Laboratories Limited (from 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Sep 2022 | 1985 | ₹637 Cr (FY 2026) | Active | |
| Director | 30 Mar 2022 | 2000 | ₹251 Cr (FY 2023) | Active | |
| Director | 30 Mar 2022 | 1999 | ₹235 Cr (FY 2024) | Active | |
| Director | 12 Nov 2020 | 1992 | ₹56.63 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Mar 2018 | 1995 | ₹100 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Meena Sanjiv Kapadi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Meena Sanjiv Kapadi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meena Sanjiv Kapadi
Meena Sanjiv Kapadi currently holds 4 directorships: Flamingo Pharmaceuticals Limited (Director, since 28 Sep 2022, revenue ₹637 Cr (FY 2026)); B4u Broadband (India) Private Limited (Director, since 30 Mar 2022, revenue ₹251 Cr (FY 2023)); B4u Television Network India Limited (Director, since 30 Mar 2022, revenue ₹235 Cr (FY 2024)); Prime Property Development Corporation Limited (Director, since 12 Nov 2020, revenue ₹56.63 Cr (FY 2024)).
Meena Sanjiv Kapadi was first appointed on 20 Mar 2018 as Director at Medibios Laboratories Limited. The most recent appointment on record is 28 Sep 2022 at Flamingo Pharmaceuticals Limited.
The 4 current companies of Meena Sanjiv Kapadi that report revenue have a combined latest revenue of ₹1,180 Cr: Flamingo Pharmaceuticals Limited ₹637 Cr (FY 2026); B4u Broadband (India) Private Limited ₹251 Cr (FY 2023); B4u Television Network India Limited ₹235 Cr (FY 2024); Prime Property Development Corporation Limited ₹56.63 Cr (FY 2024).
Meena Sanjiv Kapadi held 1 earlier board appointment: Medibios Laboratories Limited (Director, from 20 Mar 2018).
The current boards of Meena Sanjiv Kapadi's companies include Ashish Tayal (Flamingo Pharmaceuticals Limited), Ashwin Jethalal Thacker (Flamingo Pharmaceuticals Limited), Chhotulal Rawa Bhagwat (Flamingo Pharmaceuticals Limited), Parth Ashwin Thacker (Flamingo Pharmaceuticals Limited), Pranay Ashwin Thacker (Flamingo Pharmaceuticals Limited), Sukrut Jagdish Shah (Flamingo Pharmaceuticals Limited), among others.